|
DERL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.60690005535491E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.73060000002923E-07 |
| Normal-vs-Stage2 |
4.425900E-04 |
| Normal-vs-Stage3 |
1.02400000001612E-06 |
| Normal-vs-Stage4 |
1.76986999999018E-05 |
| Stage1-vs-Stage2 |
6.969600E-01 |
| Stage1-vs-Stage3 |
1.259020E-01 |
| Stage1-vs-Stage4 |
3.221600E-01 |
| Stage2-vs-Stage3 |
4.275200E-01 |
| Stage2-vs-Stage4 |
6.971600E-01 |
| Stage3-vs-Stage4 |
6.637200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.14020000002913E-08 |
| Normal-vs-AfricanAmerican |
2.38389999995814E-06 |
| Normal-vs-Asian |
7.910400E-02 |
| Caucasian-vs-AfricanAmerican |
7.050400E-01 |
| Caucasian-vs-Asian |
2.619600E-01 |
| AfricanAmerican-vs-Asian |
2.866000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.4047000007622E-08 |
| Normal-vs-Female |
3.67509999987803E-07 |
| Male-vs-Female |
9.807400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.784160E-01 |
| Normal-vs-Age(41-60Yrs) |
2.80149999976054E-07 |
| Normal-vs-Age(61-80Yrs) |
2.83159995451143E-09 |
| Normal-vs-Age(81-100Yrs) |
2.503100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.990150E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.156900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.187850E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.775400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.764000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.747400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.885500E-02 |
| Normal-vs-Grade 2 |
1.40479999855003E-08 |
| Normal-vs-Grade 3 |
1.21620000004263E-06 |
| Normal-vs-Grade 4 |
1.98589999998999E-05 |
| Grade 1-vs-Grade 2 |
1.071390E-01 |
| Grade 1-vs-Grade 3 |
3.426800E-01 |
| Grade 1-vs-Grade 4 |
1.042390E-01 |
| Grade 2-vs-Grade 3 |
3.096000E-01 |
| Grade 2-vs-Grade 4 |
6.424800E-01 |
| Grade 3-vs-Grade 4 |
2.448400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.60869999987767E-07 |
| Normal-vs-ccB subtype |
2.54209999717148E-08 |
| ccA subtype-vs-ccB subtype |
1.420040E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.04399999651039E-08 |
| Normal-vs-N1 |
1.823770E-02 |
| N0-vs-N1 |
4.210000E-01 |
|
|
